Basics OPKO Health, Inc. OPKO Health Inc is a diversified healthcare company. Its business includes diagnostics and provision of pharmaceutical products. IPO Date: November 2, 1995 Sector: Healthcare Industry: Biotech Market Cap: $1.03B Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 2.71% Avg Daily Range (30 D): $0.03 | 1.96% Avg Daily Range (90 D): $0.03 | 1.89% Institutional Daily Volume Avg Daily Volume: 3.27M Avg Daily Volume (30 D): 2.19M Avg Daily Volume (90 D): 2.03M Trade Size Avg Trade Size (Sh.): 295 Avg Trade Size (Sh.) (30 D): 289 Avg Trade Size (Sh.) (90 D): 266 Institutional Trades Total Inst.Trades: 4,492 Avg Inst. Trade: $1.81M Avg Inst. Trade (30 D): $.82M Avg Inst. Trade (90 D): $1.73M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2M Avg Closing Trade (30 D): $.82M Avg Closing Trade (90 D): $2.12M Avg Closing Volume: 448.74K     News Nov 18, 2025 @ 1:00 PM Entera Bio to Participate in the 8th Annual Everco... Source: Miranda Toledano Oct 8, 2025 @ 12:02 PM NextPlat Issues CEO Shareholder Update Letter Source: David Phipps Aug 8, 2025 @ 9:17 PM Entera Bio Beats Q2 EPS Estimates Source: Jesterai Jun 30, 2025 @ 12:01 PM NextPlat Issues Interim CEO Update Shareholder Let... Source: David Phipps Jun 25, 2025 @ 3:00 PM OPKO Health to Participate in the 3rd Annual Piper... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $.03 $-.19 Diluted EPS $.03 $-.19 Revenue $ $ 151.67M $ 156.81M Gross Profit $ $ 49.89M $ 49.4M Net Income / Loss $ $ 21.63M $ -148.44M Operating Income / Loss $ $ 48.06M $ -59.98M Cost of Revenue $ $ 101.78M $ 107.41M Net Cash Flow $ $ 143.8M $ -165.74M PE Ratio